Abstract
Acquired pendular nystagmus (APN) is regularly accompanied by oscillopsia and impairment of static visual acuity. Therapeutic approaches to APN remain controversial, and there is no generally accepted therapeutic approach. We tested 14 patients who had suffered from APN caused by multiple sclerosis for several years; 12 patients presented with fixational pendular nystagmus (increasing during fixation) and 2 with spontaneous pendular nystagmus. All 11 patients with fixational pendular nystagmus who were given memantine, a glutamate antagonist, experienced complete cessation of the nystagmus. In contrast, scopolamine caused no (6 of 8) or only a minor (10–50%) reduction of the nystagmus (2 of 8). It was concluded that memantine is a safe treatment option for APN.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 29 August 1995 Received in revised form: 6 August 1996 Accepted: 19 August 1996
Rights and permissions
About this article
Cite this article
Starck, M., Albrecht, H., Pöllmann, W. et al. Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol 244, 9–16 (1996). https://doi.org/10.1007/PL00007728
Issue Date:
DOI: https://doi.org/10.1007/PL00007728